100.99 USD
+0.01 (+0.01%)
100.99 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 54% to AMED. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 102.87. This target is 1.87% above the current price.
AMED was analyzed by 17 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about AMED.
In the previous month the buy percentage consensus was at a similar level.
AMED was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-16 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-04 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-02-12 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2024-07-31 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2024-07-25 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-07-01 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-04-25 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-03-26 | Raymond James | Maintains | Market Perform -> Market Perform |
| 2024-03-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-09-14 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2023-07-31 | TD Cowen | Maintains | Market Perform -> Market Perform |
| 2023-07-27 | Credit Suisse | Reiterate | Neutral -> Neutral |
| 2023-07-06 | Jefferies | Downgrade | Buy -> Hold |
| 2023-06-28 | Benchmark | Downgrade | Buy -> Hold |
| 2023-06-27 | Benchmark | Downgrade | Buy -> Hold |
| 2023-06-27 | Truist Securities | Maintains | Hold -> Hold |
| 2023-06-07 | Truist Securities | Downgrade | Buy -> Hold |
| 2023-06-06 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2023-06-06 | Benchmark | Reiterate | Buy -> Buy |
| 2023-06-06 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2023-05-08 | TD Cowen | Maintains | Market Perform |
| 2023-05-05 | Barclays | Maintains | Equal-Weight |
| 2023-05-04 | Stephens & Co. | Reiterate | Equal-Weight |
| 2023-05-04 | Truist Securities | Maintains | Buy |
| 2023-04-21 | Cantor Fitzgerald | Initiate | Neutral |
| 2023-04-13 | Truist Securities | Maintains | Buy |
| 2023-03-14 | Benchmark | Reiterate | Buy |
| 2023-03-14 | Stephens & Co. | Reiterate | Equal-Weight |
| 2023-03-13 | Barclays | Initiate | Equal-Weight |
| 2023-02-27 | Credit Suisse | Reiterate | Outperform |
AMEDISYS INC / AMED FAQ
What do analysts expect the price target to be for AMEDISYS INC (AMED)?
17 analysts have analysed AMED and the average price target is 102.87 USD. This implies a price increase of 1.87% is expected in the next year compared to the current price of 100.99.
What is the consensus rating for AMED stock?
The consensus rating for AMEDISYS INC (AMED) is 54.1176 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts cover AMEDISYS INC (AMED) stock?
The number of analysts covering AMEDISYS INC (AMED) is 17.